KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in IntangiblesChange in InventoryDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Cash from Investing Activities (2018 - 2025)

Historic Cash from Investing Activities for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to -$1.1 billion.

  • BioNTech SE's Cash from Investing Activities fell 59316.13% to -$1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $805.2 million, marking a year-over-year increase of 11383.66%. This contributed to the annual value of -$2.2 billion for FY2024, which is 7027.83% up from last year.
  • As of Q3 2025, BioNTech SE's Cash from Investing Activities stood at -$1.1 billion, which was down 59316.13% from -$72.9 million recorded in Q2 2025.
  • Over the past 5 years, BioNTech SE's Cash from Investing Activities peaked at $1.3 billion during Q1 2025, and registered a low of -$2.9 billion during Q4 2023.
  • For the 5-year period, BioNTech SE's Cash from Investing Activities averaged around -$451.9 million, with its median value being -$83.7 million (2022).
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first soared by 9604344356.51% in 2021, then crashed by 288312.11% in 2023.
  • BioNTech SE's Cash from Investing Activities (Quarter) stood at $114.3 million in 2021, then skyrocketed by 43.73% to $164.3 million in 2022, then crashed by 1865.35% to -$2.9 billion in 2023, then soared by 122.36% to $648.3 million in 2024, then tumbled by 266.85% to -$1.1 billion in 2025.
  • Its Cash from Investing Activities was -$1.1 billion in Q3 2025, compared to -$72.9 million in Q2 2025 and $1.3 billion in Q1 2025.